Gentiva Health Services, Inc. operates its health services business in the United States and provides specialty pharmaceutical services (including infusion therapy and distribution services) and home health care services. Gentiva Health Services Inc. has a market cap of $713.8 million; its shares were traded at around $24.52 with a P/E ratio of 12.4 and P/S ratio of 0.5. Gentiva Health Services Inc. had an annual average earning growth of 20.6% over the past 5 years.
Insiders' Positions with GTIV
- Sell:: CEO & President Tony Strange sold 3,077 shares of GTIV stock on 08/07/2009 at the average price of 20.9, the price of the stock has increased by 17.32% since
Insiders' Positions with GTIV
- Sell:: EVP, CFO & Treasurer John R Potapchuk sold 20,000 shares of GTIV stock on 08/20/2009 at the average price of 20.96, the price of the stock has increased by 16.98% since
Insiders' Positions with GTIV
- Sell:: Director Rodney D Windley sold 65,754 shares of GTIV stock on 11/23/2009 at the average price of 24.35, the price of the stock has increased by 0.7% since
- Sell:: Director Rodney D Windley sold 42,922 shares of GTIV stock on 11/17/2009 at the average price of 24.05, the price of the stock has increased by 1.95% since
- Sell:: Director Rodney D Windley sold 137,120 shares of GTIV stock on 11/11/2009 at the average price of 24.21, the price of the stock has increased by 1.28% since
- Sell:: SVP, Secretary & Gen. Counsel Stephen B Paige sold 10,517 shares of GTIV stock on 08/20/2009 at the average price of 20.85, the price of the stock has increased by 17.6% since
- Sell:: SVP, Secretary & Gen. Counsel Stephen B Paige sold 13,483 shares of GTIV stock on 08/10/2009 at the average price of 21, the price of the stock has increased by 16.76% since
Rate This Article: |
  |